[1]秦燕,王杏茶,方淑琴,等.承德市女性人乳头瘤病毒感染基因分型的临床分析[J].医学信息,2020,33(08):144-146.[doi:10.3969/j.issn.1006-1959.2020.08.047]
　QIN Yan,WANG Xing-cha,FANG Shu-qin,et al.Infection Status and Distribution Characteristics of Female HPV Subtypes in Chengde City from 2014 to 2017[J].Medical Information,2020,33(08):144-146.[doi:10.3969/j.issn.1006-1959.2020.08.047]
点击复制

承德市女性人乳头瘤病毒感染基因分型的临床分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年08期
页码:
144-146
栏目:
调查分析
出版日期:
2020-04-15

文章信息/Info

Title:
Infection Status and Distribution Characteristics of Female HPV Subtypes in Chengde City from 2014 to 2017
文章编号:
1006-1959（2020）08-0144-03
作者:
秦燕; 王杏茶; 方淑琴; 等
（承德医学院附属医院妇一科，河北 承德 067000）
Author(s):
QIN Yan; WANG Xing-cha; FANG Shu-qin; et al
(Department of Gynecology,Subject One,the Affiliated Hospital of Chengde Medical College, Chengde 067000,Hebei,China)
关键词:
人乳头瘤病毒; 宫颈癌; 基因型; 亚型分布
Keywords:
Human papillomavirus; Cervical cancer; Gnotype; Subtype distribution
分类号:
R445.1
DOI:
10.3969/j.issn.1006-1959.2020.08.047
文献标志码:
A
摘要:
目的 了解承德市女性HPV亚型感染情况及在各年龄段的分布特点，为预防HPV感染和宫颈癌防治提供参考。方法 选取2014~2017年就诊于承德医学院附属医院的16338例门诊及住院患者，采取医用核酸分子杂交系统流式荧光杂交法进行27种HPV基因亚型检测。结果 16338例样本中，阳性4392例，阳性率26.89%，27种基因亚型全部被检出，其中高危型2325例，低危型648例，混合感染型1419例。高危型HPV感染率最高的为HPV16型，其次为HPV58、52、18、53型；低危型HPV感染率最高的为HPV61型，其次为HPV6、43、81、42型，总检出率最高的为HPV16型，其次为HPV58、52、61、18型。各年龄段HPV感染分布呈双峰型，≤25岁及56~65岁HPV感染率出现高峰。结论 HPV感染存在地域差异，了解承德市女性HPV亚型感染情况及各年龄段的分布特点，加强对承德市各年龄段女性多种型别HPV的监测及筛查，可为承德市女性宫颈癌的防治提供流行病学数据，指导临床治疗。
Abstract:
Objective To understand the HPV subtype infection of women in Chengde City and their distribution characteristics at various ages,so as to provide a reference for the prevention of HPV infection and cervical cancer prevention.Methods A total of 16338 outpatients and in-patients who were admitted to the Affiliated Hospital of Chengde Medical College from 2014 to 2017 were selected,and 27 types of HPV genotypes were detected by flow fluorophore hybridization using medical nucleic acid molecular hybridization system.Results Among the 16338 samples,4392 were positive,with a positive rate of 26.89%.All 27 gene subtypes were detected,including 2325 high-risk types,648 low-risk types,and 1419 mixed infection types.High-risk HPV infection rate is the highest type HPV16,followed by HPV58,52,18,53;low-risk HPV infection rate is the highest type HPV61,followed by HPV6,43,81,42 type,the highest total detection rate type is HPV16,followed by HPV58,52,61,18 type.The distribution of HPV infection in each age group is bimodal,with peaks in HPV infection rates of≤25 years old and 56-65 years old.Conclusion There are regional differences in HPV infection,understand the HPV subtype infection status and the distribution characteristics of various age groups of women in Chengde City,strengthen the monitoring and screening of multiple types of HPV of women of all age groups in Chengde City,with a view to the cervical cancer of women in Chengde City Prevention and treatment provides epidemiological data to guide clinical treatment.

参考文献/References:

[1]谢幸,苟文丽主编.妇产科学［M］.第9版,北京:人民卫生出版社,2018:295.[2]Clifford GM,Gallus S,Herrero R,et al.Worldw ide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys:a prevalence surveys:a pooled analysis[J].2005(366):991-998.[3]彭园园,赵丽娟,高虹,等.石家庄地区5092例女性HPV感染基因型分型[J].中华实验和临床病毒学杂志,2015,29(4):289-291.[4]吴林玲,闰颖,韩志平.天津地区女性人乳头瘤病毒感染情况及亚型分布特征分析［J].海南医学,2013,24(13):1922－1925.[5]智艳芳,李肖甫,班振英,等.河南地区女性HPV感染及基因型分型研究[J],中华肿瘤防治杂志,2014,21(9):660-664.[6]张青,杨真,袁小林,等.大连地区2755例不同年龄组HPV亚型感染状况分型[J],现代预防医学杂志,2014,41(2):345-348.[7]李静霞,刘文利,刘悦君,等.邯郸地区女性人乳头瘤病毒感染基因型分布特点临床分析[J].中国妇幼保健,2017,32(30):4926-4928.[8]胥萍,陈慧,吴敏娟,等.江苏省女性 HPV 感染基因型［J].中国公共卫生,2014,30(5):618-621.[9］章玉珍,马向东,刘明辉,等.西安市长安区妇科就诊妇女高危型HPV感染及亚型分布调查研究［J].中国现代医药杂志,2012,14(4):38-41.[10]高燕,张志军,梁文通,等.人乳头瘤病毒多重感染与宫颈病变的相关性研究[J].中华医院感染学杂志,2016(46):4041-4043.

相似文献/References:

[1]廖加群,曹 雪,陈燕平,等.宫颈癌盆腔淋巴结转移分布及危险因素分析[J].医学信息,2018,31(03):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
　LIAO Jia-qun,CAO Xue,CHEN Yan-ping,et al.Distribution and Risk Factors of Pelvic Lymph Node Metastasis in Cervical Cancer[J].Medical Information,2018,31(08):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
[2]徐 洁.宫颈癌筛查及预防的研究进展[J].医学信息,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
　XU Jie.Advances in Screening and Prevention of Cervical Cancer[J].Medical Information,2018,31(08):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
[3]黄 花,徐冬冬,章丽霞.TGF-β1在宫颈癌中的研究进展[J].医学信息,2018,31(12):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
　HUANG Hua,XU Dong-dong,ZHANG Li-xia.Research Progress of TGF-β1 in Cervical Cancer[J].Medical Information,2018,31(08):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
[4]夏易曼娜,李虎成.腹腔镜下宫颈癌根治术与传统开腹手术的对比研究[J].医学信息,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
　XIA Yi-manna,LI Hu-cheng.Comparative Study of Laparoscopic Radical Resection of Cervical Cancer and Traditional Open Surgery[J].Medical Information,2018,31(08):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
[5]杨 军,王翠平,李 龙,等.义安区体检HPV-DNA筛查结果分析[J].医学信息,2018,31(14):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
　YANG Jun,WANG Cui-ping,LI Long,et al.Analysis of the Results of HPV-DNA Screening in the Medical Examination of Yian District[J].Medical Information,2018,31(08):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
[6]王双英,张 娜,刘 芳.具有高危复发因素的早期宫颈癌术后辅助治疗进展[J].医学信息,2018,31(15):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
　WANG Shuang-ying,ZHANG Na,LIU Fang.Advances in Postoperative Adjuvant Therapy for Early Cervical Cancer with High Risk of Recurrence[J].Medical Information,2018,31(08):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
[7]聂小凤,翟慧慧,冷天艳,等.宫颈脱落细胞miR34a检测在HR-HPV阳性患者 分流中的作用分析[J].医学信息,2018,31(16):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
　NIE Xiao-feng,ZHAI Hui-hui,LENG Tian-yan,et al.Analysis of the Role of MiR34a in Cervical Exfoliated Cells in Shunt of HR-HPV Positive Patients[J].Medical Information,2018,31(08):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
[8]吴晓玲,周桂华.miR-187在宫颈癌中的表达与临床病理关系的研究[J].医学信息,2018,31(16):69.[doi:10.3969/j.issn.1006-1959.2018.16.019]
　WU Xiao-ling,ZHOU Gui-hua.Expression of miR-187 in Cervical Cancer and Its Relationship with Clinicopathological Features[J].Medical Information,2018,31(08):69.[doi:10.3969/j.issn.1006-1959.2018.16.019]
[9]莫宗平,刘 巧,蒋佳利.安岳地区女性高危型HPV基因分型结果分析[J].医学信息,2018,31(18):101.[doi:10.3969/j.issn.1006-1959.2018.18.031]
　MO Zong-ping,LIU Qiao,JIANG Jia-li.Analysis of the Results of High-risk HPV Genotyping in Women in Anyue Area[J].Medical Information,2018,31(08):101.[doi:10.3969/j.issn.1006-1959.2018.18.031]
[10]邬素珍,许焕英.宫颈人乳头瘤病毒感染的免疫研究进展[J].医学信息,2018,31(19):33.[doi:10.3969/j.issn.1006-1959.2018.19.012]
　WU Su-zhen,XU Huan-ying.Progress in Immunization of Cervical Human Papillomavirus Infection[J].Medical Information,2018,31(08):33.[doi:10.3969/j.issn.1006-1959.2018.19.012]
[11]代艳文,吴大富.宜昌地区妇女人乳头瘤病毒感染状况分析[J].医学信息,2020,33(16):143.[doi:10.3969/j.issn.1006-1959.2020.16.045]
　DAI Yan-wen,WU Da-fu.Analysis of Women’s Human Papillomavirus Infection in Yichang Area[J].Medical Information,2020,33(08):143.[doi:10.3969/j.issn.1006-1959.2020.16.045]
[12]张 晴,杨勇莉.p16在宫颈癌发生发展中的作用[J].医学信息,2022,35(01):59.[doi:10.3969/j.issn.1006-1959.2022.01.014]
　ZHANG Qing,YANG Yong-li.Role of p16 in the Development of Cervical Cancer[J].Medical Information,2022,35(08):59.[doi:10.3969/j.issn.1006-1959.2022.01.014]
[13]穆红茹.中晚期宫颈癌的非手术治疗进展[J].医学信息,2022,35(15):167.[doi:10.3969/j.issn.1006-1959.2022.15.040]
　MU Hong-ru.Advances in Nonsurgical Treatment of Cervical Cancer in the Middle and Late Stage[J].Medical Information,2022,35(08):167.[doi:10.3969/j.issn.1006-1959.2022.15.040]
[14]翁梦晴,韦彩萍,任文宁,等.基于CiteSpace的人乳头瘤病毒疫苗可视化分析[J].医学信息,2023,36(03):39.[doi:10.3969/j.issn.1006-1959.2023.03.009]
　WENG Meng-qing,WEI Cai-ping,REN Wen-ning,et al.Visual Analysis of Human Papillomavirus Vaccine Based on CiteSpace[J].Medical Information,2023,36(08):39.[doi:10.3969/j.issn.1006-1959.2023.03.009]

更新日期/Last Update: 2020-04-15